Cargando…
Design and Synthesis of AMPK Activators and GDF15 Inducers
Targeting growth differentiation factor 15 (GDF15) is a recent strategy for the treatment of obesity and type 2 diabetes mellitus (T2DM). Here, we designed, synthesized, and pharmacologically evaluated in vitro a novel series of AMPK activators to upregulate GDF15 levels. These compounds were struct...
Autores principales: | Zhang, Meijian, Bagán, Andrea, Martínez, Donna, Barroso, Emma, Palomer, Xavier, Vázquez, Santiago, Escolano, Carmen, Vázquez-Carrera, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386161/ https://www.ncbi.nlm.nih.gov/pubmed/37513338 http://dx.doi.org/10.3390/molecules28145468 |
Ejemplares similares
-
The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance
por: Aguilar-Recarte, David, et al.
Publicado: (2021) -
CHOP upregulation and dysregulation of the mature form of the SNAT2 amino acid transporter in the placentas from small for gestational age newborns
por: Barroso, Emma, et al.
Publicado: (2023) -
The Role of Peroxisome Proliferator-Activated Receptor β/δ on the Inflammatory Basis of Metabolic Disease
por: Coll, Teresa, et al.
Publicado: (2010) -
SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2
por: Barroso, Emma, et al.
Publicado: (2020) -
PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
por: Palomer, Xavier, et al.
Publicado: (2018)